OARSI 2016: Efficacy of intramuscular corticosteroid injection vs. placebo for hip OA .
Intramuscular corticosteroid injection versus placebo effective in pain reduction in patients with hip osteoarthritis
107 patients with osteoarthritis of the hip were randomized to receive either an intramuscular (IM) corticosteroid injection (gluteal) or placebo injection for the purpose of determining if an intramuscular corticosteroid injection was associated with significantly improved pain, function, and stiffness after a 12-week follow-up period. Results demonstrated that NRS pain, WOMAC pain, stiffness, function, and ICOAP score significantly favored patients who received corticosteroid injection while demonstrating comparable rates of adverse events and co-intervention medication throughout the study duration.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!